Global Endocrine Testing Market Report 2024

Endocrine Testing Global Market Report 2025 – By Test Type (Estradiol (E, Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types), By Technology (Tandem Mass Spectrometry, Immunoassay, Monoclonal & Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies), By End-User (Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Endocrine Testing Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Endocrine Testing Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Endocrine Testing Market Definition

Endocrine testing refers to the diagnostic process of evaluating hormone levels in the body, typically through blood, urine, or saliva tests, to assess the function of the endocrine system. These tests are crucial for diagnosing various endocrine disorders, including diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders. Endocrine testing helps healthcare providers determine the appropriate treatment and management plans for patients with these conditions.

The main types of endocrine testing include estradiol (E2) test, follicle stimulating hormone (FSH) test, human chorionic gonadotropin (HCG) hormone test, luteinizing hormone (LH) test, dehydroepiandrosterone sulfate (DHEAS) test, progesterone test, testosterone test, thyroid stimulating hormone (TSH) test, prolactin test, and others. The Estradiol (E2) Test refers to a blood test that measures the levels of estradiol in the body. They are based on various technologies including tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody technologies, sensor technology, clinical chemistry, and others used by hospitals, clinical laboratories, diagnostic centers, and others.

Endocrine Testing Market Segmentation

The endocrine testing market covered in this report is segmented –

1) By Test Type: Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types

2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies

3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users

Subsegments:

1) By Estradiol (E2) Test: Serum Estradiol Test, Urinary Estradiol Test

2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test, FSH Urine Test

3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test, Qualitative hCG Test

4) By Luteinizing Hormone (LH) Test: LH Serum Test, LH Urine Test

5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test, Saliva DHEAS Test

6) By Progesterone Test: Serum Progesterone Test, Urinary Progesterone Test

7) By Testosterone Test: Free Testosterone Test, Total Testosterone Test

8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test, TSH Saliva Test

9) By Prolactin Test: Serum Prolactin Test, Plasma Prolactin Test

10) By Other Types: Cortisol Test, Insulin Test, Growth Hormone (GH) Test, Aldosterone Test

Endocrine Testing Market Size and growth rate 2025 to 2029: Graph

Endocrine Testing Market Size 2025 And Growth Rate

The endocrine testing market size has grown strongly in recent years. It will grow from $2.55 billion in 2024 to $2.8 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to discovery of hormones and endocrine pathways, diagnostic test standardization, public health initiatives, and patient advocacy and empowerment.

Endocrine Testing Market Growth Forecast

The endocrine testing market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growing prevalence of endocrine disorders, increased defense spending, aging population, awareness and early diagnosis, and increased awareness. Major trends in the forecast period include advancements in biomarker detection, integration of omics technologies, artificial intelligence and machine learning, quality assurance and standardization, and collaborative research and translational medicine.

Endocrine Testing Market Driver: Impact of Diabetes Prevalence on Endocrine Testing Market Growth

The rising prevalence of diabetes is expected to propel the growth of the endocrine testing market going forward. Diabetes refers to a group of diseases that result in high blood sugar (glucose) levels. The prevalence of diabetes is increasing due to factors such as unhealthy diets, sedentary lifestyles, genetic predisposition, and an aging population. Endocrine testing, including hemoglobin A1c, fasting plasma glucose, and C-peptide tests, is used in diabetes to diagnose the condition, monitor glucose levels, and assess insulin production and sensitivity. For instance, in June 2024, according to the National Health Service (NHS), UK-based government department, among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This significant growth highlights a concerning trend in this age group. The data reflects a rapid escalation in diabetes prevalence among younger populations. Therefore, the rising prevalence of diabetes is driving the endocrine testing market.

Global Endocrine Testing Market Major Players

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

Global Endocrine Testing Market Trend: Point-Of-Care NT-Probnp Test For Cardiovascular Risk Screening In Diabetic Patients

Major companies operating in the endocrine testing market are developing point-of-care testing solutions to enhance the accessibility and efficiency of diagnosing endocrine disorders. Point-of-care testing allows for quick results, which can aid in the rapid diagnosis and management of heart failure in patients presenting with symptoms such as shortness of breath and fatigue. For instance, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, launched a point-of-care NT-proBNP test in India, specifically designed for screening diabetes patients at risk of cardiovascular diseases, such as heart failure (HF). It facilitates early detection and intervention, enabling clinicians to identify high-risk T2D patients and initiate timely treatment discussions. The test facilitates early detection and intervention, allowing the clinicians to identify high-risk T2D patients and initiate timely treatment discussions, ultimately fostering improved outcomes and patient well-being.

Endocrine Testing Market Merger And Acquisition: Tolmar Pharmaceuticals Inc. Acquired JATENZO From Clarus Therapeutics Holdings Inc

In October 2022, Tolmar, a US-based pharmaceutical company acquired Jatenzo from Clarus Therapeutics for an undisclosed amount. Through this acquisition, Jatenzo, a testosterone replacement therapy, complements Tolmar's focus on pediatric endocrinology and men's health, enhancing their portfolio of specialty pharmaceutical products. Clarus Therapeutics is a US-based pharmaceutical company focused on developing and commercializing therapies for people with endocrine disorders.

Regional Outlook For The Global Endocrine Testing Market

North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Endocrine Testing Market?

The endocrine testing market consists of revenues earned by entities by providing services such as hormone level testing, thyroid function testing, diabetes testing, adrenal function testing, reproductive hormone testing, pituitary function testing, and bone metabolism testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine testing market also includes sales of assay kits, analyzers, point-of-care testing devices, reagents, software solutions, quality control materials, and calibrators and controls. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Endocrine Testing Industry?

The endocrine testing market research report is one of a series of new reports from The Business Research Company that provides endocrine testing market statistics, including endocrine testing industry global market size, regional shares, competitors with a endocrine testing market share, detailed endocrine testing market segments, market trends and opportunities, and any further data you may need to thrive in the endocrine testing industry. This endocrine testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Endocrine Testing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $2.8 billion
Revenue Forecast In 2034 $4.01 billion
Growth Rate CAGR of 9.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Test Type: Estradiol (E
2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types
2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users Subsegments: 1) By Estradiol (E
2) Test: Serum Estradiol Test, Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test, FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test, Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test, LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test, Saliva DHEAS Test 6) By Progesterone Test: Serum Progesterone Test, Urinary Progesterone Test 7) By Testosterone Test: Free Testosterone Test, Total Testosterone Test 8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test, TSH Saliva Test 9) By Prolactin Test: Serum Prolactin Test, Plasma Prolactin Test 10) By Other Types: Cortisol Test, Insulin Test, Growth Hormone (GH) Test, Aldosterone Test
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Endocrine Testing Market Characteristics

    3. Endocrine Testing Market Trends And Strategies

    4. Endocrine Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Endocrine Testing Growth Analysis And Strategic Analysis Framework

    5.1. Global Endocrine Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Endocrine Testing Market Growth Rate Analysis

    5.4. Global Endocrine Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Endocrine Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Endocrine Testing Total Addressable Market (TAM)

    6. Endocrine Testing Market Segmentation

    6.1. Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Estradiol (E2) Test

    Follicle Stimulating Hormone (FSH) Test

    Human Chorionic Gonadotropin (hCG) Hormone Test

    Luteinizing Hormone (LH) Test

    Dehydroepiandrosterone Sulfate (DHEAS) Test

    Progesterone Test

    Testosterone Test

    Thyroid Stimulating Hormone (TSH) Test

    Prolactin Test

    Other Types

    6.2. Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tandem Mass Spectrometry

    Immunoassay

    Monoclonal And Polyclonal Antibody Technologies

    Sensor Technology

    Clinical Chemistry

    Other Technologies

    6.3. Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinical Laboratories

    Diagnostic Centers

    Other End-Users

    6.4. Global Endocrine Testing Market, Sub-Segmentation Of Estradiol (E2) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Serum Estradiol Test

    Urinary Estradiol Test

    6.5. Global Endocrine Testing Market, Sub-Segmentation Of Follicle Stimulating Hormone (FSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    FSH Serum Test

    FSH Urine Test

    6.6. Global Endocrine Testing Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG) Hormone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Quantitative hCG Test

    Qualitative hCG Test

    6.7. Global Endocrine Testing Market, Sub-Segmentation Of Luteinizing Hormone (LH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    LH Serum Test

    LH Urine Test

    6.8. Global Endocrine Testing Market, Sub-Segmentation Of Dehydroepiandrosterone Sulfate (DHEAS) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Serum DHEAS Test

    Saliva DHEAS Test

    6.9. Global Endocrine Testing Market, Sub-Segmentation Of Progesterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Serum Progesterone Test

    Urinary Progesterone Test

    6.10. Global Endocrine Testing Market, Sub-Segmentation Of Testosterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Free Testosterone Test

    Total Testosterone Test

    6.11. Global Endocrine Testing Market, Sub-Segmentation Of Thyroid Stimulating Hormone (TSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    TSH Serum Test

    TSH Saliva Test

    6.12. Global Endocrine Testing Market, Sub-Segmentation Of Prolactin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Serum Prolactin Test

    Plasma Prolactin Test

    6.13. Global Endocrine Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cortisol Test

    Insulin Test

    Growth Hormone (GH) Test

    Aldosterone Test

    7. Endocrine Testing Market Regional And Country Analysis

    7.1. Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Endocrine Testing Market

    8.1. Asia-Pacific Endocrine Testing Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Endocrine Testing Market

    9.1. China Endocrine Testing Market Overview

    9.2. China Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Endocrine Testing Market

    10.1. India Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Endocrine Testing Market

    11.1. Japan Endocrine Testing Market Overview

    11.2. Japan Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Endocrine Testing Market

    12.1. Australia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Endocrine Testing Market

    13.1. Indonesia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Endocrine Testing Market

    14.1. South Korea Endocrine Testing Market Overview

    14.2. South Korea Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Endocrine Testing Market

    15.1. Western Europe Endocrine Testing Market Overview

    15.2. Western Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Endocrine Testing Market

    16.1. UK Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Endocrine Testing Market

    17.1. Germany Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Endocrine Testing Market

    18.1. France Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Endocrine Testing Market

    19.1. Italy Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Endocrine Testing Market

    20.1. Spain Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Endocrine Testing Market

    21.1. Eastern Europe Endocrine Testing Market Overview

    21.2. Eastern Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Endocrine Testing Market

    22.1. Russia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Endocrine Testing Market

    23.1. North America Endocrine Testing Market Overview

    23.2. North America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Endocrine Testing Market

    24.1. USA Endocrine Testing Market Overview

    24.2. USA Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Endocrine Testing Market

    25.1. Canada Endocrine Testing Market Overview

    25.2. Canada Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Endocrine Testing Market

    26.1. South America Endocrine Testing Market Overview

    26.2. South America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Endocrine Testing Market

    27.1. Brazil Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Endocrine Testing Market

    28.1. Middle East Endocrine Testing Market Overview

    28.2. Middle East Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Endocrine Testing Market

    29.1. Africa Endocrine Testing Market Overview

    29.2. Africa Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Endocrine Testing Market Competitive Landscape And Company Profiles

    30.1. Endocrine Testing Market Competitive Landscape

    30.2. Endocrine Testing Market Company Profiles

    30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Roche Holding Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

    31. Endocrine Testing Market Other Major And Innovative Companies

    31.1. Agilent Technologies Inc.

    31.2. PerkinElmer Inc.

    31.3. BioMérieux SA

    31.4. Beckman Coulter Inc.

    31.5. Bio-Rad Laboratories Inc.

    31.6. SD Biosensor Inc.

    31.7. Qiagen N.V.

    31.8. Ortho Clinical Diagnostics

    31.9. Kronus Inc.

    31.10. Randox Laboratories Ltd.

    31.11. Fujirebio Diagnostics Inc.

    31.12. Inova Diagnostics Inc.

    31.13. Sekisui Diagnostics LLC

    31.14. Mercodia AB

    31.15. ZEUS Scientific Inc.

    32. Global Endocrine Testing Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Endocrine Testing Market

    34. Recent Developments In The Endocrine Testing Market

    35. Endocrine Testing Market High Potential Countries, Segments and Strategies

    35.1 Endocrine Testing Market In 2029 - Countries Offering Most New Opportunities

    35.2 Endocrine Testing Market In 2029 - Segments Offering Most New Opportunities

    35.3 Endocrine Testing Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Endocrine Testing Market, Sub-Segmentation Of Estradiol (E2) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Endocrine Testing Market, Sub-Segmentation Of Follicle Stimulating Hormone (FSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Endocrine Testing Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG) Hormone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Endocrine Testing Market, Sub-Segmentation Of Luteinizing Hormone (LH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Endocrine Testing Market, Sub-Segmentation Of Dehydroepiandrosterone Sulfate (DHEAS) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Endocrine Testing Market, Sub-Segmentation Of Progesterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Endocrine Testing Market, Sub-Segmentation Of Testosterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Endocrine Testing Market, Sub-Segmentation Of Thyroid Stimulating Hormone (TSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Endocrine Testing Market, Sub-Segmentation Of Prolactin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Endocrine Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: Thermo Fisher Scientific Inc. Financial Performance
  • Table 85: Abbott Laboratories Financial Performance
  • Table 86: Roche Holding Financial Performance
  • Table 87: Siemens Healthineers Financial Performance
  • Table 88: Quest Diagnostics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Endocrine Testing Market, Sub-Segmentation Of Estradiol (E2) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Endocrine Testing Market, Sub-Segmentation Of Follicle Stimulating Hormone (FSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Endocrine Testing Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG) Hormone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Endocrine Testing Market, Sub-Segmentation Of Luteinizing Hormone (LH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Endocrine Testing Market, Sub-Segmentation Of Dehydroepiandrosterone Sulfate (DHEAS) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Endocrine Testing Market, Sub-Segmentation Of Progesterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Endocrine Testing Market, Sub-Segmentation Of Testosterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Endocrine Testing Market, Sub-Segmentation Of Thyroid Stimulating Hormone (TSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Endocrine Testing Market, Sub-Segmentation Of Prolactin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Endocrine Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 85: Abbott Laboratories Financial Performance
  • Figure 86: Roche Holding Financial Performance
  • Figure 87: Siemens Healthineers Financial Performance
  • Figure 88: Quest Diagnostics Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Endocrine Testing market?

Endocrine testing refers to the diagnostic process of evaluating hormone levels in the body, typically through blood, urine, or saliva tests, to assess the function of the endocrine system. These tests are crucial for diagnosing various endocrine disorders, including diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders. Endocrine testing helps healthcare providers determine the appropriate treatment and management plans for patients with these conditions. For further insights on the Endocrine Testing market, request a sample here

How will the Endocrine Testing market drivers and restraints affect the market dynamics? What forces will shape the Endocrine Testing industry going forward?

The Endocrine Testing market major growth driver - Impact of Diabetes Prevalence on Endocrine Testing Market Growth. For further insights on the Endocrine Testing market, request a sample here

What is the forecast market size or the forecast market value of the Endocrine Testing market?

The Endocrine Testing market size has grown strongly in recent years. The endocrine testing market size has grown strongly in recent years. It will grow from $2.55 billion in 2024 to $2.8 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to discovery of hormones and endocrine pathways, diagnostic test standardization, public health initiatives, and patient advocacy and empowerment. The endocrine testing market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growing prevalence of endocrine disorders, increased defense spending, aging population, awareness and early diagnosis, and increased awareness. Major trends in the forecast period include advancements in biomarker detection, integration of omics technologies, artificial intelligence and machine learning, quality assurance and standardization, and collaborative research and translational medicine. For further insights on the Endocrine Testing market, request a sample here

How is the Endocrine Testing market segmented?

The endocrine testing market covered in this report is segmented –
1) By Test Type: Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types
2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users
Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test, Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test, FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test, Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test, LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test, Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test, Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test, Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test, TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test, Plasma Prolactin Test
10) By Other Types: Cortisol Test, Insulin Test, Growth Hormone (GH) Test, Aldosterone Test For further insights on the Endocrine Testing market,
request a sample here

Which region has the largest share of the Endocrine Testing market? What are the other regions covered in the report?

North America was the largest region in the endocrine testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Endocrine Testing market, request a sample here.

Who are the major players in the Endocrine Testing market?

Major companies operating in the endocrine testing market are developing point-of-care testing solutions to enhance the accessibility and efficiency of diagnosing endocrine disorders. Point-of-care testing allows for quick results, which can aid in the rapid diagnosis and management of heart failure in patients presenting with symptoms such as shortness of breath and fatigue. For instance, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, launched a point-of-care NT-proBNP test in India, specifically designed for screening diabetes patients at risk of cardiovascular diseases, such as heart failure (HF). It facilitates early detection and intervention, enabling clinicians to identify high-risk T2D patients and initiate timely treatment discussions. The test facilitates early detection and intervention, allowing the clinicians to identify high-risk T2D patients and initiate timely treatment discussions, ultimately fostering improved outcomes and patient well-being.. For further insights on the Endocrine Testing market, request a sample here.

What are the key trends in the Endocrine Testing market?

Major trends in the Endocrine Testing market include Point-Of-Care NT-Probnp Test For Cardiovascular Risk Screening In Diabetic Patients. For further insights on the Endocrine Testing market, request a sample here.

What are the major opportunities in the Endocrine Testing market? What are the strategies for the Endocrine Testing market?

For detailed insights on the major opportunities and strategies in the Endocrine Testing market, request a sample here.

How does the Endocrine Testing market relate to the overall economy and other similar markets?

For detailed insights on Endocrine Testing's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Endocrine Testing industry?

For detailed insights on the mergers and acquisitions in the Endocrine Testing industry, request a sample here.

What are the key dynamics influencing the Endocrine Testing market growth? SWOT analysis of the Endocrine Testing market.

For detailed insights on the key dynamics influencing the Endocrine Testing market growth and SWOT analysis of the Endocrine Testing industry, request a sample here.